Xu Yiyun, Zhang Qinxin, Wang Yan, Zhou Ran, Ji Xiuqing, Meng Lulu, Luo Chunyu, Liu An, Jiao Jiao, Chen Hao, Zeng Huasha, Hu Ping, Xu Zhengfeng
Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Health Care Hospital, Nanjing 210004, China.
Diagnostics (Basel). 2024 Jan 11;14(2):165. doi: 10.3390/diagnostics14020165.
Optical genome mapping (OGM) has been known as an all-in-one technology for chromosomal aberration detection. However, there are also aberrations beyond the detection range of OGM. This study aimed to report the aberrations missed by OGM and analyze the contributing factors. OGM was performed by taking both GRCh37 and GRCh38 as reference genomes. The OGM results were analyzed in blinded fashion and compared to standard assays. Quality control (QC) metrics, sample types, reference genome, effective coverage and classes and locations of aberrations were then analyzed. In total, 154 clinically reported variations from 123 samples were investigated. OGM failed to detect 10 (6.5%, 10/154) aberrations with GRCh37 assembly, including five copy number variations (CNVs), two submicroscopic balanced translocations, two pericentric inversion and one isochromosome (mosaicism). All the samples passed pre-analytical and analytical QC. With GRCh38 assembly, the false-negative rate of OGM fell to 4.5% (7/154). The breakpoints of the CNVs, balanced translocations and inversions undetected by OGM were located in segmental duplication (SD) regions or regions with no DLE-1 label. In conclusion, besides variations with centromeric breakpoints, structural variations (SVs) with breakpoints located in large repetitive sequences may also be missed by OGM. GRCh38 is recommended as the reference genome when OGM is performed. Our results highlight the necessity of fully understanding the detection range and limitation of OGM in clinical practice.
光学基因组图谱(OGM)一直被认为是一种用于染色体畸变检测的一体化技术。然而,也存在超出OGM检测范围的畸变。本研究旨在报告OGM遗漏的畸变并分析其影响因素。采用GRCh37和GRCh38作为参考基因组进行OGM。对OGM结果进行盲法分析,并与标准检测方法进行比较。然后分析质量控制(QC)指标、样本类型、参考基因组、有效覆盖范围以及畸变的类别和位置。总共调查了来自123个样本的154个临床报告变异。使用GRCh37组装时,OGM未能检测到10个(6.5%,10/154)畸变,包括5个拷贝数变异(CNV)、2个亚微观平衡易位、2个臂间倒位和1个等臂染色体(嵌合体)。所有样本均通过分析前和分析阶段的QC。使用GRCh38组装时,OGM的假阴性率降至4.5%(7/154)。OGM未检测到的CNV、平衡易位和倒位的断点位于节段性重复(SD)区域或无DLE-1标记的区域。总之,除了具有着丝粒断点的变异外,OGM也可能遗漏断点位于大的重复序列中的结构变异(SV)。进行OGM时,建议使用GRCh38作为参考基因组。我们的结果凸显了在临床实践中充分了解OGM检测范围和局限性的必要性。